These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28166153)

  • 1. Cerebral Parenchymal Photopenia on FDG-PET/CT Reflecting Vasogenic Edema Due to Leptomeningeal Metastasis in Breast Cancer.
    Ishiyama M; Matesan MC
    Clin Nucl Med; 2017 Apr; 42(4):285-286. PubMed ID: 28166153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT Imaging of Cauda Equina Syndrome Secondary to Leptomeningeal Metastatic Breast Cancer.
    Solnes LB; Javadi MS; Rowe SP
    Clin Nucl Med; 2016 Nov; 41(11):e485-e486. PubMed ID: 27607169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare Esophageal Leptomeningeal Metastases Detected on 18F-FDG PET/CT.
    Lu Y; Wang L; Ajani JA
    Clin Nucl Med; 2020 Apr; 45(4):334-335. PubMed ID: 31977493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of F-18 PET/CT in the Detection of Leptomeningeal Metastasis.
    Short RG; Bal S; German JP; Poelstra RJ; Kardan A
    Neuroradiol J; 2014 Dec; 27(6):685-9. PubMed ID: 25489891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Bottle Brush Sign"-Spinal Meningeal Disease on 18F-FDG PET-CT Scan.
    Riaz S; Naz F; Bashir H; Niazi IK
    Clin Nucl Med; 2016 Sep; 41(9):726-7. PubMed ID: 27405033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic brain lesions may demonstrate photopenia on FDG-PET.
    Liu Y
    Clin Nucl Med; 2008 Apr; 33(4):255-7. PubMed ID: 18356662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma.
    Hao B; Wu J; Pang Y; Sun L; Chen H
    Clin Nucl Med; 2020 Oct; 45(10):784-786. PubMed ID: 32796242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG and (82)Rb PET/MRI features of brain metastasis of breast cancer.
    Lu Y
    Clin Nucl Med; 2015 Jun; 40(6):494-5. PubMed ID: 25674864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma.
    Fonti R; Salvatore B; De Renzo A; Nicolai E; Del Vecchio S
    Clin Nucl Med; 2016 Feb; 41(2):169-72. PubMed ID: 26545028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
    Melsaether AN; Raad RA; Pujara AC; Ponzo FD; Pysarenko KM; Jhaveri K; Babb JS; Sigmund EE; Kim SG; Moy LA
    Radiology; 2016 Oct; 281(1):193-202. PubMed ID: 27023002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases.
    D'Souza MM; Jaimini A; Tripathi M; Garg N; Sharma R; Monndal A; Tripathi RP
    Clin Nucl Med; 2012 Feb; 37(2):206-9. PubMed ID: 22228356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG uptakes in leptomeningeal metastases from carcinoma of the breast on a positron emission tomography/computerized tomography study.
    Shah S; Rangarajan V; Purandare N; Luthra K; Medhi S
    Indian J Cancer; 2007; 44(3):115-8. PubMed ID: 18250534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-methionine PET imaging of leptomeningeal metastases from primary breast cancer--a case report.
    Padma MV; Jacobs M; Kraus G; Collins M; Dunigan K; Mantil J
    J Neurooncol; 2001 Oct; 55(1):39-44. PubMed ID: 11804281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
    Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
    Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
    Liang X; Yu J; Wen B; Xie J; Cai Q; Yang Q
    Clin Radiol; 2017 Apr; 72(4):295-301. PubMed ID: 28139203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
    Schmitz AMT; Teixeira SC; Pengel KE; Loo CE; Vogel WV; Wesseling J; Rutgers EJT; Valdés Olmos RA; Sonke GS; Rodenhuis S; Vrancken Peeters MJTFD; Gilhuijs KGA
    PLoS One; 2017; 12(5):e0176782. PubMed ID: 28531188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT reveals the primary tumor in a patient with occult breast carcinoma undetected by other modalities.
    Liu M; Liu B; Song Y; Ding L; Dong L
    Clin Nucl Med; 2014 Aug; 39(8):755-7. PubMed ID: 24978343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.